Navigation Links
New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
Date:6/25/2013

Toronto, Canada (PRWEB) June 25, 2013

During this webinar, experts from SQI Diagnostics and Algorithme Pharma will discuss the use of a unique multiplexed immunoassay system to characterize Anti-Drug-Antibody (ADA) interaction.

A case study will be presented on Heparin-induced thrombocytopenia (HIT) antibodies developed in response to heparin, or its low molecular weight analogues using the SQI Diagnostics’ platform. This case study will illustrate the capabilities of the novel SQiDlite™ system in assessing the immunogenicity of a wide variety of biologic therapeutics which is required in safety and efficacy studies.

To learn more about the event, visit: http://xtalks.com/multiplexed-immunogenicity-assessment-sqidlite.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10842048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Cost-Effective Approaches to Quality Distribution and Logistics for Temperature Sensitive Products
2. Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing”
3. ICD-10 Coding Knowledge Assessment Tool Released
4. Riordan Clinic Research Institute Has Developed and Patented a Process for the Assessment of the Energy Metabolism in Patients with Chronic Fatigue Syndrome
5. Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
6. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
7. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
9. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
10. BioInformatics LLC New Product Launch – RateMyProduct, a Quick Turnaround Product Assessment Tool for Life Science Suppliers
11. Research and Markets Announces Addition of the "Risk - Reward of Developing a Herceptin Biosimilar - A Thorough Assessment" Report to its Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been solving ... of the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today is ... Kati Abraham , who is well known in the industry and brings significant ...
(Date:6/16/2017)... Lexington, Massachusetts (PRWEB) , ... June 16, 2017 ... ... in medical device compliance and commercialization, has just announced two more sessions of ... of the series will focus on the world of online templates for design ...
(Date:6/16/2017)... ... June 16, 2017 , ... CTNext , Connecticut’s go-to resource ... held at The LOFT at Chelsea Piers in Stamford. , Nine finalists, all of ... of judges for an opportunity to secure $10,000 awards to help support business growth. ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... a Series B round of financing in the amount of $6 million. An ... investors participated in the round. , The Series B funding will enable Cybrexa ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):